Therapeutic potential of PPARγ natural agonists in liver diseases

J Cell Mol Med. 2020 Mar;24(5):2736-2748. doi: 10.1111/jcmm.15028. Epub 2020 Feb 7.

Abstract

Peroxisome proliferator-activated receptor gamma (PPARγ) is a vital subtype of the PPAR family. The biological functions are complex and diverse. PPARγ plays a significant role in protecting the liver from inflammation, oxidation, fibrosis, fatty liver and tumours. Natural products are a promising pool for drug discovery, and enormous research effort has been invested in exploring the PPARγ-activating potential of natural products. In this manuscript, we will review the research progress of PPARγ agonists from natural products in recent years and probe into the application potential and prospects of PPARγ natural agonists in the therapy of various liver diseases, including inflammation, hepatic fibrosis, non-alcoholic fatty liver and liver cancer.

Keywords: PPARγ; liver diseases; natural agonists.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biological Products / chemistry
  • Biological Products / therapeutic use*
  • Humans
  • Liver Diseases / drug therapy*
  • Liver Diseases / pathology
  • Models, Biological
  • PPAR gamma / agonists*
  • PPAR gamma / chemistry
  • PPAR gamma / genetics
  • PPAR gamma / metabolism

Substances

  • Biological Products
  • PPAR gamma